M
Marc Schindewolf
Researcher at University of Bern
Publications - 83
Citations - 1155
Marc Schindewolf is an academic researcher from University of Bern. The author has contributed to research in topics: Medicine & Fondaparinux. The author has an hindex of 19, co-authored 70 publications receiving 983 citations. Previous affiliations of Marc Schindewolf include Goethe University Frankfurt.
Papers
More filters
Journal ArticleDOI
Incidence and causes of heparin-induced skin lesions
Marc Schindewolf,Svantje Schwaner,Manfred Wolter,Hartmut Kroll,Andreas Recke,Roland Kaufmann,Wolf-Henning Boehncke,Edelgard Lindhoff-Last,Ralf Ludwig +8 more
TL;DR: Heparin-induced skin lesions are relatively common, have identifiable risk factors and are commonly caused by a delayed-type hypersensitivity reaction (type IV allergic response).
Journal ArticleDOI
Heparin-induced skin lesions
TL;DR: The clinical range of heparin-induced skin lesions is reviewed, evidence and controversies in epidemiology, diagnosis, and differential diagnosis are emphasised, and the management of patients with these skin lesions are discussed.
Journal ArticleDOI
The Role of Platelets in Venous Thromboembolism
TL;DR: The mechanisms that link platelets with venous thrombotic disease and their potential applications as novel risk factors for VTE are discussed and their role as a suitable therapeutic target for V TE prevention is acknowledged.
Journal ArticleDOI
Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
Marc Schindewolf,Julia Steindl,Jan Beyer-Westendorf,Sebastian Schellong,Pascal M. Dohmen,Johannes Brachmann,Katharina Madlener,Bernd Pötzsch,Robert Klamroth,Johannes Hankowitz,Norbert Banik,Sonja Eberle,Stefan Kropff,Markus Michael Müller,Edelgard Lindhoff-Last +14 more
TL;DR: There is a wide fondaparinux off-label use (up to 50.3%) for suspected HIT, even in those patients with a high clinical pretest probability, despite the current diagnostic laboratory strategy based on the recommended 2-step strategy.
Journal ArticleDOI
Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis - Results from the MAISTHRO registry
Birgit Linnemann,Florian Meister,Jan Schwonberg,Marc Schindewolf,Dimitrios Zgouras,Edelgard Lindhoff-Last +5 more
TL;DR: Thrombophilia is a common finding in patients with UE-DVT, especially in those with thrombosis that is unrelated to venous catheters, and is the only thromBophilia that is differentially expressed after controlling for established VTE risk factors.